BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35120281)

  • 1. HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease.
    Ås J; Bertulyte I; Eriksson N; Magnusson PKE; Wadelius M; Hallberg P
    Clin Transl Sci; 2022 May; 15(5):1249-1256. PubMed ID: 35120281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease.
    Wilson A; Jansen LE; Rose RV; Gregor JC; Ponich T; Chande N; Khanna R; Yan B; Jairath V; Khanna N; Sey M; Beaton M; McIntosh K; Teft WA; Kim RB
    Aliment Pharmacol Ther; 2018 Mar; 47(5):615-620. PubMed ID: 29270995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.
    Heap GA; Weedon MN; Bewshea CM; Singh A; Chen M; Satchwell JB; Vivian JP; So K; Dubois PC; Andrews JM; Annese V; Bampton P; Barnardo M; Bell S; Cole A; Connor SJ; Creed T; Cummings FR; D'Amato M; Daneshmend TK; Fedorak RN; Florin TH; Gaya DR; Greig E; Halfvarson J; Hart A; Irving PM; Jones G; Karban A; Lawrance IC; Lee JC; Lees C; Lev-Tzion R; Lindsay JO; Mansfield J; Mawdsley J; Mazhar Z; Parkes M; Parnell K; Orchard TR; Radford-Smith G; Russell RK; Reffitt D; Satsangi J; Silverberg MS; Sturniolo GC; Tremelling M; Tsianos EV; van Heel DA; Walsh A; Watermeyer G; Weersma RK; Zeissig S; Rossjohn J; Holden AL; ; ; Ahmad T
    Nat Genet; 2014 Oct; 46(10):1131-4. PubMed ID: 25217962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Wilson A; Wang Q; Choi YH; Ponich T; Gregor JC; Chande N; Yan B; Sey M; Beaton M; Kim RB
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00332. PubMed ID: 33821842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease.
    Silverberg MS; Mirea L; Bull SB; Murphy JE; Steinhart AH; Greenberg GR; McLeod RS; Cohen Z; Wade JA; Siminovitch KA
    Inflamm Bowel Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12656131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients.
    Pascual-Oliver A; Casas-Deza D; Cuarán C; García-López S; Corsino-Roche P; Sierra-Moros E; Olier-Martínez P; González-Tarancón R; Vicente-Lidón R
    Inflamm Bowel Dis; 2024 Jun; 30(6):922-929. PubMed ID: 37462462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.
    Teich N; Mohl W; Bokemeyer B; Bündgens B; Büning J; Miehlke S; Hüppe D; Maaser C; Klugmann T; Kruis W; Siegmund B; Helwig U; Weismüller J; Drabik A; Stallmach A;
    J Crohns Colitis; 2016 Jan; 10(1):61-8. PubMed ID: 26468141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
    Ledder O; Lemberg DA; Day AS
    Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
    Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
    Weersma RK; Peters FT; Oostenbrug LE; van den Berg AP; van Haastert M; Ploeg RJ; Posthumus MD; Homan van der Heide JJ; Jansen PL; van Dullemen HM
    Aliment Pharmacol Ther; 2004 Oct; 20(8):843-50. PubMed ID: 15479355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study.
    Wintzell V; Svanström H; Olén O; Melbye M; Ludvigsson JF; Pasternak B
    Lancet Child Adolesc Health; 2019 Mar; 3(3):158-165. PubMed ID: 30685366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
    Kaushansky N; Eisenstein M; Boura-Halfon S; Hansen BE; Nielsen CH; Milo R; Zeilig G; Lassmann H; Altmann DM; Ben-Nun A
    J Biol Chem; 2015 Jun; 290(24):15260-78. PubMed ID: 25911099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease?
    Weersma RK; Batstra MR; Kleibeuker JH; van Dullemen HM
    JOP; 2008 May; 9(3):283-9. PubMed ID: 18469440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-linked susceptibility and resistance genes in Crohn's disease.
    Nakajima A; Matsuhashi N; Kodama T; Yazaki Y; Takazoe M; Kimura A
    Gastroenterology; 1995 Nov; 109(5):1462-7. PubMed ID: 7557126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children.
    Nowak JK; Glapa-Nowak A; Banaszkiewicz A; Iwańczak B; Kwiecień J; Szaflarska-Popławska A; Grzybowska-Chlebowczyk U; Osiecki M; Kierkuś J; Hołubiec M; Chanaj-Kaczmarek J; Radzikowski A; Walkowiak J
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele.
    Forcione DG; Sands B; Isselbacher KJ; Rustgi A; Podolsky DK; Pillai S
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5094-8. PubMed ID: 8643533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.